Procurement Summary
Country: Ukraine
Summary: Epinephrine 1.82 Mg/Ml, Solution for Injection, Ampoule; Povidone-Iodine, Ointment/Liniment, 10%, 20 G Each; Validol Tablets 60 Mg Each; Valerian Extract Tablets, Coated, 30 Mg Each; Theophylline Solution For...
Deadline: 03 Nov 2026
Posting Date: 31 Oct 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 151781022
Document Ref. No.: UA-2026-10-29-002973-a
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: UAH 39252.34
CPV Classification
33600000 - Pharmaceutical products
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33630000 - Medicinal products for dermatology and the musculo-skeletal system
33660000 - Medicinal products for the nervous system and sensory organs
33670000 - Medicinal products for the respiratory system
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Epinephrine 1.82 mg/ml, solution for injection, ampoule; Povidone-iodine, ointment/liniment, 10%, 20 g each; Validol tablets 60 mg each; Valerian extract tablets, coated, 30 mg each; Theophylline solution for injection 20 mg/ml in 5 ml; Caffeine sodium benzoate, solution for injection, 100 mg/ml, 1 ml each; Captopril/hydrochlorothiazide, tablets, 50/12.5 mg each; Validol tablets of 100 mg; Pancreatin, Lipolytic units: 8000; Ibuprofen tablets/capsules of 400 mg; Ethyl alcohol 70% 100 ml.; Chlorhexidine, a solution for external use of 0.05% per 200 ml; Metamizole sodium, 500 mg tablets; Diamond green solution for external use, alcohol 1%, 20 ml; Activated charcoal tablets/capsules of 250 mg each; Dexamethasone, solution for injection 4mg/ml; Diclofenac solution for injection 25 mg/ml; Ethamsylate solution for injection, 125 mg/ml in 2 ml; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each; Drotaverin solution for injections 20 mg/ml, 2 ml in an ampoule; Hydrogen peroxide, solution, 3%, 200 ml each; Metamizole sodium 500 mg pitofenone hydrochloride 5 mg fenpiverinium bromide 0.1 mg, tablets; Chloropyramine, solution for injection, 20 mg/ml, 1 ml each; Iodine, solution for external use, 5%, 20 ml each; Loperamide 2 mg tablets/capsules; Loratadine 10 mg tablets; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Sodium chloride, solution for injection, 9 mg/ml, 5 ml each; Sodium chloride, solution for infusions, 9 mg/ml 200 ml; Acetylsalicylic acid 240 mg/paracetamol 180 mg/caffeine 30 mg, tablets; Where...
Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Chlorhexidine, solution for external use application of 0.05% per 200 ml; Ethamsylate solution for injection, 125 mg/ml in 2 ml; Dexpanthenol dermal foam 50 mg/g per 58 g Classification according to ATH: D03AX03, Classification according to INN: Dexpanthenol, Release form: Skin foam, Dose of active substance, Volume: 58 g, Packaging type: Container, Tube, Vial; Classification according to ATX: N05CB02, Classification according to INN: Barbiturates in combination with other drugs, Release form: Oral drops, Volume: 25 milliliter, Type of packaging: Vial, Ethyl ether of alpha-bromisovaleric acid: 18 mg, Phenobarbital: 17 mg, Solution of menthol in menthyl ether of isovaleric acid (validol): 80 mg; Classification according to ATX: N05CB02, Classification according to INN: Barbiturat... Also NameClassifier and its corresponding codeQuantity/Measurement unitsPlace of deliveryDate of deliveryName
Ethamsylate solution for injection, 125 mg/ml in 2 ml; Dexpanthenol foam for the skin 50 mg/g per 58 g Classification according to ATX: D03AX03, Classification according to the INN: Dexpanthenol, Release form: Dermal foam, Dose of the active substance, Volume: 58 g, Packaging type: Container, Tube, Vial; Classification according to ATX: N05CB02, Classification according to INN: Barbiturates in combination with other drugs, Release form: Oral drops, Volume: 25 milliliter...
Documents
Tender Notice